Oman Launches OMR 6.5 Million Radiopharmaceutical Facility

On 8 November, Oman Investment Authority launched the Oman Nucleus project with an estimated investment of OMR 6.5 million to produce radiopharmaceuticals for diagnosis and treatment. The project creates opportunities in medical equipment, laboratory systems and pharmaceutical supply chains. HPC can help identify qualified healthcare suppliers and technical partners.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.